Centers for Disease Control and Prevention. Basic statistics: HIV 2022 [updated June 21, 2022. Available from: https://www.cdc.gov/hiv/basics/statistics.html.

The Global HIV/AIDS Epidemic [Accessed: August 6, 2022] [Available from: https://www.hiv.gov/hiv-basics/overview/data-and-trends/global-statistics.

Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas HSSR, 27(No. 6). http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html . Published May 2022. Accessed [August 6.

Wong C, Gange SJ, Buchacz K, Moore RD, Justice AC, Horberg MA, et al. First occurrence of diabetes, chronic kidney disease, and hypertension among North American HIV-infected adults, 2000–2013. Clin Infect Dis. 2017;64(4):459–67.

Google Scholar 

Heron JE, Bagnis CI, Gracey DM. Contemporary issues and new challenges in chronic kidney disease amongst people living with HIV. AIDS Res Ther. 2020;17(1):11.

Article  Google Scholar 

Gameiro J, Agapito Fonseca J, Jorge S, Lopes JA. Acute kidney injury in HIV-infected patients: a critical review. HIV Med. 2019;20(2):77–87.

Article  CAS  Google Scholar 

Abraham AG, Althoff KN, Jing Y, Estrella MM, Kitahata MM, Wester CW, et al. End-stage renal disease among HIV-infected adults in North America. Clin Infect Dis. 2015;60(6):941–9.

Article  Google Scholar 

Nichols B, Jog P, Lee JH, Blackler D, Wilmot M, D’Agati V, et al. Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1. Kidney Int. 2015;87(2):332–42.

Article  CAS  Google Scholar 

Kruzel-Davila E, Shemer R, Ofir A, Bavli-Kertselli I, Darlyuk-Saadon I, Oren-Giladi P, et al. APOL1-Mediated Cell Injury Involves Disruption of Conserved Trafficking Processes. J Am Soc Nephrol. 2017;28(4):1117–30.

Article  CAS  Google Scholar 

Beckerman P, Bi-Karchin J, Park AS, Qiu C, Dummer PD, Soomro I, et al. Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice. Nat Med. 2017;23(4):429–38.

Article  CAS  Google Scholar 

Limou S, Nelson GW, Kopp JB, Winkler CA. APOL1 kidney risk alleles: population genetics and disease associations. Adv Chronic Kidney Dis. 2014;21(5):426–33.

Article  Google Scholar 

Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science. 2010;329(5993):841–845 (This study identifed APOL1 genetic variation as the strongest risk of kidney disease in Blacks of African descent.)

Article  CAS  Google Scholar 

Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, et al. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol. 2011;22(11):2129–37.

Article  CAS  Google Scholar 

Dummer PD, Limou S, Rosenberg AZ, Heymann J, Nelson G, Winkler CA, et al. APOL1 kidney disease risk variants: an evolving landscape. Semin Nephrol. 2015;35(3):222–36.

Article  CAS  Google Scholar 

Fine DM, Wasser WG, Estrella MM, Atta MG, Kuperman M, Shemer R, et al. APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease. J Am Soc Nephrol. 2012;23(2):343–50.

Article  CAS  Google Scholar 

Atta MG, Estrella MM, Kuperman M, Foy MC, Fine DM, Racusen LC, et al. HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics. Kidney Int. 2012;82(3):338–43.

Article  CAS  Google Scholar 

Mocroft A, Neuhaus J, Peters L, Ryom L, Bickel M, Grint D, et al. Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults. PLoS ONE. 2012;7(7):e40245.

Article  CAS  Google Scholar 

Shen TC, Huang KY, Chao CH, Wang YC, Muo CH, Wei CC, et al. The risk of chronic kidney disease in tuberculosis: a population-based cohort study. QJM. 2015;108(5):397–403.

Article  Google Scholar 

Jha V, Prasad N. CKD and infectious diseases in Asia Pacific: challenges and opportunities. Am J Kidney Dis. 2016;68(1):148–60.

Article  Google Scholar 

Hung RKY, Binns-Roemer E, Booth JW, Hilton R, Fox J, Burns F, et al. Sickle cell trait and kidney disease in people of African ancestry with HIV. Kidney Int Rep. 2022;7(3):465–73.

Article  Google Scholar 

Choi AI, Li Y, Parikh C, Volberding PA, Shlipak MG. Long-term clinical consequences of acute kidney injury in the HIV-infected. Kidney Int. 2010;78(5):478–85.

Article  Google Scholar 

Likanonsakul S, Suntisuklappon B, Nitiyanontakij R, Prasithsirikul W, Nakayama EE, Shioda T, et al. A single-nucleotide polymorphism in ABCC4 is associated with tenofovir-related Beta2-microglobulinuria in Thai patients with HIV-1 infection. PLoS ONE. 2016;11(1):e0147724.

Article  Google Scholar 

Thompson MA, Horberg MA, Agwu AL, Colasanti JA, Jain MK, Short WR, et al. Primary care guidance for persons with human immunodeficiency virus: 2020 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2021;73(11):e3572–605.

Article  Google Scholar 

George E, Lucas GM, Nadkarni GN, Fine DM, Moore R, Atta MG. Kidney function and the risk of cardiovascular events in HIV-1-infected patients. AIDS. 2010;24(3):387–94 (This study provided a strong evidence of the independent association of either proteinuria or low glomerular filtration rate in people living with HIV and cardiovascular events.)

Article  Google Scholar 

Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41.

Article  CAS  Google Scholar 

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.

Article  Google Scholar 

Atta MG, Zook K, Brown TT, Vaidya D, Tao X, Maier P, et al. Racial adjustment adversely affects glomerular filtration estimates in Black Americans living with HIV. J Am Soc Nephrol. 2021;32(9):2143–7 (This study demonstrated that estimated glomerular filtration rate in Black Americans living with HIV should not include racial adjustment.)

Article  Google Scholar 

Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737–49.

Article  CAS  Google Scholar 

Tabatabai S, Sperati CJ, Atta MG, Janjua K, Roxbury C, Lucas GM, et al. Predictors of complication after percutaneous ultrasound-guided kidney biopsy in HIV-infected individuals: possible role of hepatitis C and HIV co-infection. Clin J Am Soc Nephrol. 2009;4(11):1766–73.

Article  Google Scholar 

Berliner AR, Fine DM, Lucas GM, Rahman MH, Racusen LC, Scheel PJ, et al. Observations on a cohort of HIV-infected patients undergoing native renal biopsy. Am J Nephrol. 2008;28(3):478–86 (This study provided data on the evolution of kidney disease in people living with HIV in the pre- and post-ART era.)

Article  Google Scholar 

Rao TK, Filippone EJ, Nicastri AD, Landesman SH, Frank E, Chen CK, et al. Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med. 1984;310(11):669–73.

Article  CAS  Google Scholar 

Dijkman HB, Weening JJ, Smeets B, Verrijp KC, van Kuppevelt TH, Assmann KK, et al. Proliferating cells in HIV and pamidronate-associated collapsing focal segmental glomerulosclerosis are parietal epithelial cells. Kidney Int. 2006;70(2):338–44.

Article  CAS  Google Scholar 

Moudgil A, Nast CC, Bagga A, Wei L, Nurmamet A, Cohen AH, et al. Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int. 2001;59(6):2126–33.

Article  CAS  Google Scholar 

Pardo V, Meneses R, Ossa L, Jaffe DJ, Strauss J, Roth D, et al. AIDS-related glomerulopathy: occurrence in specific risk groups. Kidney Int. 1987;31(5):1167–73.

Article  CAS  Google Scholar 

Estrella M, Fine DM, Gallant JE, Rahman MH, Nagajothi N, Racusen LC, et al. HIV type 1 RNA level as a clinical indicator of renal pathology in HIV-infected patients. Clin Infect Dis. 2006;43(3):377–80.

Article  Google Scholar 

Ahuja TS, Borucki M, Funtanilla M, Shahinian V, Hollander M, Rajaraman S. Is the prevalence of HIV-associated nephropathy decreasing? Am J Nephrol. 1999;19(6):655–9.

Article  CAS  Google Scholar 

Langs C, Gallo GR, Schacht RG, Sidhu G, Baldwin DS. Rapid renal failure in AIDS-associated focal glomerulosclerosis. Arch Intern Med. 1990;150(2):287–92.

Article  CAS  Google Scholar 

Waheed S, Atta MG. Predictors of HIV-associated nephropathy. Expert Rev Anti Infect Ther. 2014;12(5):555–63.

Article  CAS  Google Scholar 

Foy MC, Estrella MM, Lucas GM, Tahir F, Fine DM, Moore RD, et al. Comparison of risk factors and outcomes in HIV immune complex kidney disease and HIV-associated nephropathy. Clin J Am Soc Nephrol. 2013;8(9):1524–32.

Article  Google Scholar 

Parkhie SM, Fine DM, Lucas GM, Atta MG. Characteristics of patients with HIV and biopsy-proven acute interstitial nephritis. Clin J Am Soc Nephrol. 2010;5(5):798–804.

Article  Google Scholar 

Franco-Paredes C, Rebolledo P, Folch E, Hernandez I, del Rio C. Diagnosis of diffuse CD8+ lymphocytosis syndrome in HIV-infected patients. AIDS Read. 2002;12(9):408–13.

Google Scholar 

Croucher A, Vera J, Akolo C, Roufosse C, Holden B, Cooke G. Acute renal failure due to immune reconstitution inflammatory interstitial nephritis in an HIV-positive patient. AIDS. 2010;24(11):1788–90.

Article  Google Scholar 

Melica G, Matignon M, Desvaux D, Audard V, Copie-Bergman C, Lang P, et al. Acute interstitial nephritis with predominant plasmacytic infiltration in patients with HIV-1 infection. Am J Kidney Dis. 2012;59(5):711–4.

Article  Google Scholar 

Röling J, Schmid H, Fischereder M, Draenert R, Goebel FD. HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy. Clin Infect Dis. 2006;42(10):1488–95.

Article  Google Scholar 

Fine DM, Perazella MA, Lucas GM, Atta MG. Renal disease in patients with HIV infection: epidemiology, pathogenesis and management. Drugs. 2008;68(7):963–80.

Article  CAS  Google Scholar 

Swanepoel CR, Atta MG, D’Agati VD, Estrella MM, Fogo AB, Naicker S, et al. Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2018;93(3):545–59 (This report provides the most comprehensive international guidelines on diagnosis and management of kidney disease in people living with HIV.)

Article  Google Scholar 

Lalezari JP, Henry K, O’Hearn M, Montaner JS, Piliero PJ, Trottier B, et al. Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America. N Engl J Med. 2003;348(22):2175–85.

Article  CAS  Google Scholar